IFNγ signaling also promotes MET activation and induce immune checkpoints via enhanced MET-STAT4-PD-L1 axis in tumor cells, providing tumor cells with immune evasion mechanism (33, 35, 36). The gene discussed is MET; the disease is neoplasm.